Abstract
We report a case of vaccine-associated paralytic poliomyelitis (VAPP) in an immunocompromised patient with acute lymphocytic leukemia who was initially diagnosed with aseptic meningitis. Isolation of Sabin-like type 1 poliovirus from the patient’s cerebrospinal fluid made this a case of vaccine-related poliovirus (VRPV) infection. The patient developed paralysis and respiratory distress and deceased a few months after onset of paralysis with respiratory failure. This tragic case report highlights the emergence of VAPP and indicates the importance of timely diagnosis of VRPV infections to improve clinical management of VRPV-infected patients and to prevent the devastating consequences of silent introduction of VRPVs in treatment wards and eventually in the society.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aylward B, Yamada T (2011) The polio endgame. N Engl J Med 364(24):2273–2275. https://doi.org/10.1056/NEJMp1104329
Burns CC, Diop OM, Sutter RW, Kew OM (2014) Vaccine-derived polioviruses. J Infect Dis 210:283–293
Cassemiro KM, Burlandy FM, Barbosa MR, Chen Q, Jorba J, Hachich EM, Sato MI, Burns CC, da Silva EE (2016) Molecular and phenotypic characterization of a highly evolved type 2 vaccine-derived poliovirus isolated from seawater in Brazil, 2014. PLoS One 11(3):e0152251. https://doi.org/10.1371/journal.pone.0152251
de Oliveira LH, Struchiner CJ (2000) Vaccine-associated paralytic poliomyelitis: a retrospective cohort study of acute flaccid paralyses in Brazil. Int J Epidemiol 29(4):757–763. https://doi.org/10.1093/ije/29.4.757
Estivariz CF, Molnar Z, Venczel L, Kapusinszky B, Zingeser JA, Lipskaya GY, Kew OM, Berencsi G, Csohan A (2011) Paralytic poliomyelitis associated with Sabin monovalent and bivalent oral polio vaccines in Hungary. Am J Epidemiol 174(3):316–325. https://doi.org/10.1093/aje/kwr070
Foiadelli T, Savasta S, Battistone A, Kota M, Passera C, Fiore S, Bino S, Amato C, Lozza A, Marseglia GL, Fiore L (2016) Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis. BMC Infect Dis 16(1):277. https://doi.org/10.1186/s12879-016-1587-y
Kim SJ, Kim SH, Jee YM, Kim JS (2007) Vaccine-associated paralytic poliomyelitis: a case report of flaccid monoparesis after oral polio vaccine. J Korean Med Sci 22(2):362–364. https://doi.org/10.3346/jkms.2007.22.2.362
Naeini AE, Ghazavi M, Moghim S, Sabaghi A, Fadaei R (2015) Acute flaccid paralysis surveillance: a 6 years study, Isfahan, Iran. Adv Biomed Res 4:99
Orenstein WA, Committee on Infectious Diseases (2015) Eradicating polio: how the world’s pediatricians can help stop this crippling illness forever. Pediatrics 135(1):196–202. https://doi.org/10.1542/peds.2014-3163
Pons-Salort M, Burns CC, Lyons H, Blake IM, Jafari H, Oberste MS, Kew OM, Grassly NC (2016) Preventing vaccine-derived poliovirus emergence during the polio endgame. PLoS Pathog 12(7):e1005728. https://doi.org/10.1371/journal.ppat.1005728
Schubert A, Bottcher S, Eis-Hubinger AM (2016) Two cases of vaccine-derived poliovirus infection in an oncology ward. N Engl J Med 374(13):1296–1298. https://doi.org/10.1056/NEJMc1508104
Shahmahmoodi S, Parvaneh N, Burns C, Asghar H, Mamishi S, Tabatabaie H, Chen Q, Teimourian S, Gooya MM, Esteghamati AR, Mousavi T, Yousefi M, Farrokhi K, Mashlool M, Kew O, Nategh R (2008) Isolation of a type 3 vaccine-derived poliovirus (VDPV) from an Iranian child with X-linked agammaglobulinemia. Virus Res 137(1):168–172. https://doi.org/10.1016/j.virusres.2008.07.006
Shahmahmoodi S, Mamishi S, Aghamohammadi A, Aghazadeh N, Tabatabaie H, Gooya MM, Zahraei SM, Mousavi T, Yousefi M, Farrokhi K, Mohammadpour M, Ashrafi MR, Nategh R, Parvaneh N (2010) Vaccine-associated paralytic poliomyelitis in immunodeficient children, Iran, 1995-2008. Emerg Infect Dis 16(7):1133–1136. https://doi.org/10.3201/eid1607.091606
Sharma DK, Nalavade UP, Varose SY, Deshpande JM (2015) Vaccine-derived polioviruses not detected by global surveillance screening assay. Emerg Infect Dis 21(10):1880–1881. https://doi.org/10.3201/eid2110.150702
Sutter RW, John TJ, Jain H, Agarkhedkar S, Ramanan PV, Verma H, Deshpande J, Singh AP, Sreevatsava M, Malankar P, Burton A, Chatterjee A, Jafari H, Aylward RB (2010) Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial. Lancet 376(9753):1682–1688. https://doi.org/10.1016/S0140-6736(10)61230-5
Toole MJ (2016) So close: remaining challenges to eradicating polio. BMC Med 14(1):43. https://doi.org/10.1186/s12916-016-0594-6
Financial support
This study was funded by Bushehr University of Medical Sciences with grant number 4359.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Taherkhani, R., Farshadpour, F. & Ravanbod, M.R. Vaccine-associated paralytic poliomyelitis in a patient with acute lymphocytic leukemia. J. Neurovirol. 24, 372–375 (2018). https://doi.org/10.1007/s13365-017-0610-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13365-017-0610-4